In our current study, we have shown through microbial transfer into antibiotic-treated mice that the gut microbiome changes induced by bariatric surgery impart resistance to weight gain and NAFLD through altered glucose-dependent insulinotropic polypeptide (GIP) hormone signaling. Here, GIP is linked to metabolic dysfunction-associated steatotic liver disease.